These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4570135)

  • 1. A model for drug use with depressed patients.
    Raskin A; Boothe H; Schulterbrandt JG; Reatig N; Odle D
    J Nerv Ment Dis; 1973 Feb; 156(2):130-42. PubMed ID: 4570135
    [No Abstract]   [Full Text] [Related]  

  • 2. A guide for drug use in depressive disorders.
    Raskin A
    Am J Psychiatry; 1974 Feb; 131(2):181-5. PubMed ID: 4358190
    [No Abstract]   [Full Text] [Related]  

  • 3. Age-sex differences in response to antidepressant drugs.
    Raskin A
    J Nerv Ment Dis; 1974 Aug; 159(2):120-30. PubMed ID: 4850465
    [No Abstract]   [Full Text] [Related]  

  • 4. The NIMH collaborative depression studies--a progress report.
    Raskin A
    Psychopharmacol Bull; 1972 Jul; 8(3):55-9. PubMed ID: 4559524
    [No Abstract]   [Full Text] [Related]  

  • 5. The endogenous--neurotic distinction as a predictor of response to antidepressant drugs.
    Raskin A; Crook TH
    Psychol Med; 1976 Feb; 6(1):59-70. PubMed ID: 935298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of rating scales completed by psychiatrists, nurses and patients to antidepressant drug effects.
    Raskin A; Crook TH
    J Psychiatr Res; 1976; 13(1):31-41. PubMed ID: 966189
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of anti-depressant drugs on psychodynamics.
    Bellak L; Rosenberg S
    Psychosomatics; 1966; 7(2):106-14. PubMed ID: 5325692
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential response to chlorpromazine, imipramine, and placebo. A study of subgroups of hospitalized depressed patients.
    Raskin A; Schulterbrandt JG; Reatig N; McKeon JJ
    Arch Gen Psychiatry; 1970 Aug; 23(2):164-73. PubMed ID: 4913665
    [No Abstract]   [Full Text] [Related]  

  • 9. Depression subtypes and response to phenelzine, diazepam, and a placebo. Results of a nine hospital collaborative study.
    Raskin A; Schulterbrandt JG; Reatig N; Crook TH; Odle D
    Arch Gen Psychiatry; 1974 Jan; 30(1):66-75. PubMed ID: 4587069
    [No Abstract]   [Full Text] [Related]  

  • 10. Chlorpromazine-chlordiazepoxide and chlorpromazine-imipramine treatment of newly hospitalized, acutely ill psychiatric patients.
    Michaux MH; Kurland AA; Agallianos DD
    Curr Ther Res Clin Exp; 1966 Mar; 8(3):Suppl:117-52. PubMed ID: 4956162
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparative trial of imipramine and chlorpromazine in depressed patients.
    Paykel ES; Price JS; Gillan RU; Palmai G; Chesser ES
    Br J Psychiatry; 1968 Oct; 114(515):1281-7. PubMed ID: 4880979
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of ECT in affective and schizophrenic illness.
    Greenblatt M
    Am J Psychiatry; 1977 Sep; 134(9):1001-5. PubMed ID: 331967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressants in black and white inpatients. Differential response to a controlled trial of chlorpromazine and imipramine.
    Raskin A; Crook TH
    Arch Gen Psychiatry; 1975 May; 32(5):643-9. PubMed ID: 1092283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy of chlorpromazine-procyclidine combination, imipramine and placebo in depressive disorders.
    Fink M; Klein DF; Kramer JC
    Psychopharmacologia; 1965 Jan; 7(1):27-36. PubMed ID: 5318921
    [No Abstract]   [Full Text] [Related]  

  • 15. Relevance of DMS-III depressive subtype and chronicity of antidepressant efficacy in atypical depression. Differential response to phenelzine, imipramine, and placebo.
    Stewart JW; McGrath PJ; Quitkin FM; Harrison W; Markowitz J; Wager S; Leibowitz MR
    Arch Gen Psychiatry; 1989 Dec; 46(12):1080-7. PubMed ID: 2686575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant specificity in atypical depression.
    Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison WM; Markowitz JS; Rabkin JG; Tricamo E; Goetz DM; Klein DF
    Arch Gen Psychiatry; 1988 Feb; 45(2):129-37. PubMed ID: 3276282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affective disease health maintenance organization. Patterns of lithium response.
    Shelley EM; Mendlewicz J; Fieve RR
    N Y State J Med; 1974 Sep; 74(10):1766-8. PubMed ID: 4606182
    [No Abstract]   [Full Text] [Related]  

  • 18. Phenelzine v imipramine in atypical depression. A preliminary report.
    Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison W; Rabkin J; Tricamo E; Markowitz JS; Klein DF
    Arch Gen Psychiatry; 1984 Jul; 41(7):669-77. PubMed ID: 6375621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychopharmacologic validation of atypical depression.
    Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison W; Rabkin JG; Tricamo E; Markowitz JS; Klein DF
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):22-5. PubMed ID: 6376483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of phenelzine and imipramine in depressed inpatients.
    Davidson JR; McLeod MN; Turnbull CD; Miller RD
    J Clin Psychiatry; 1981 Oct; 42(10):395-7. PubMed ID: 7026542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.